Gulf Pharmaceutical Industries PJSC (Julphar), one of the largest pharmaceutical manufacturers in the Middle East and Africa, announces the divestment of DiabTec LLC. DiabTec is a 100% owned subsidiary of Julphar and manufactures recombinant human Insulin API. The transaction is expected to be
